Survival statistics for acute myeloid leukemia
Survival statistics for acute myeloid leukemia (AML) are very general estimates and must be interpreted very carefully. Because these statistics are based on the experience of groups of people, they cannot be used to predict a particular person’s chances of survival.
There are many different ways to measure and report cancer survival statistics. Your doctor can explain these statistics and what they mean to you.
Net survival @(Model.HeadingTag)>
Net survival represents the probability (chance) of surviving cancer in the absence of other causes of death. It is used to give an estimate of the percentage of people who will survive cancer.
In Canada, the 5-year net survival for all subtypes of AML is 21%. This means that, on average, about 21% of people diagnosed with AML will live for at least 5 years.
Net survival by age group @(Model.HeadingTag)>
The net survival for AML varies by age group.
|Age group||5-year net survival|
|15 to 44||62%|
|45 to 54||42%|
|55 to 64||25%|
|65 to 74||10%|
Survival for acute promyelocytic leukemia @(Model.HeadingTag)>
Acute promyelocytic leukemia (APL) is a subtype of AML that is often treated very successfully. This success is reflected in the survival statistics. About 90% of people diagnosed with APL reach a complete remission. About 70% to 90% of people with APL who reach remission have long-term survival, and doctors consider them to be cured.
Questions about survival @(Model.HeadingTag)>
If you have AML, talk to your doctor about your prognosis. Prognosis depends on many factors, including:
- your medical history
- type of cancer
- characteristics of the cancer
- treatments chosen
- response to treatment
Only a doctor familiar with these factors can put all of this information together with survival statistics to arrive at a prognosis.
John Storring, MD, CM
Robert Turner, MD, FRCPC
Canadian Cancer Statistics Advisory Committee. Canadian Cancer Statistics 2019 . Toronto, ON : Canadian Cancer Society; 2019: https://www.cancer.ca/en/cancer-information/cancer-101/canadian-cancer-statistics/past-editions-canadian-cancer-statistics/.
Statistics Canada. Table 13-10-0160-01 Age-standardized five-year net survival estimates for primary sites of cancer, by sex, three years combined . https://www.statcan.gc.ca/en/start.
American Cancer Society. Treating Acute Myeloid Leukemia (AML) . 2018: www.cancer.org.
Kotiah SD. Medscape Reference: Acute Promyelocytic Leukemia (APL) . WebMD LLC; 2021: https://www.medscape.com/.